Metraipolis › archive › dc_982df4d4ac1b

Quaternary Phosphonium Salts Outperformed Vemurafenib (PLX) and Etoposide Against BRAFV600D,V600E PLX-Resistant Melanoma and MDR Neuroblastoma, Exhibiting… — Europe PMC PMID:41977352

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41977352
DOI
10.3390/ijms27073170
License (as archived)
solo-consultazione
Archived
2026-11-03T15:09:42.192Z
SHA-256 of the archived text
77bedc0288c84f0236d44593e5fd63208f5c07436329038314bc18c04a69d12a
Stable URL of this page
https://metraipolis.com/documento/dc_982df4d4ac1b

How to cite

Quaternary Phosphonium Salts Outperformed Vemurafenib (PLX) and Etoposide Against BRAFV600D,V600E PLX-Resistant Melanoma and MDR Neuroblastoma, Exhibiting… — Europe PMC PMID:41977352 — Europe PMC (en), https://europepmc.org/article/MED/41977352 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_982df4d4ac1b (Metraipolis archive dc_982df4d4ac1b, sha256 77bedc0288c84f0236d44593e5fd63208f5c07436329038314bc18c04a69d12a)
BibTeX
@misc{dc982df4d4ac1b,
  title = {Quaternary Phosphonium Salts Outperformed Vemurafenib (PLX) and Etoposide Against BRAFV600D,V600E PLX-Resistant Melanoma and MDR Neuroblastoma, Exhibiting… — Europe PMC PMID:41977352},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41977352},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_982df4d4ac1b; sha256 77bedc0288c84f0236d44593e5fd63208f5c07436329038314bc18c04a69d12a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41977352. Agents can read the archived copy with the MCP tool read_document.